Evidence for decisions that cannot rely on assertion.
Organisations routinely invest millions in systems whose failure could create significant operational, regulatory or reputational consequences. AGDA™ exists to answer whether intervention remains possible before those consequences become irreversible.
You are not buying activity. You are buying evidence.
The value of an Intervention Readiness assessment is determined by the significance of the decision it supports: deployment, high-risk system approval, regulatory scrutiny, board assurance, operational resilience or executive confidence.
- Executive leadership
Can we proceed with confidence?
Evidence for deployment, approval and risk-acceptance decisions where assertion is not enough.
- Risk leadership
Can intervention still occur before harm becomes irreversible?
A measured view of detection, escalation, decision and intervention capability against a reversibility window.
- Board & audit committee
What evidence supports this decision?
A formal AGDA™ SEDI verdict and signed regulator bundle that can be verified after the decision is made.
What every assessment produces.
A single structured output: an Intervention Readiness Verdict and Failure Exposure Report. Three audience layers, all derived from the same result, engine hash and, for formal SEDI assessments, attestation envelope.
-
Executive.
CRO, board, audit committeeHeadline verdict, viability status, critical failure summary, regulatory exposure, priority actions. One-page decision frame.
-
Operational.
Head of Operational Resilience, Head of Model RiskPlus temporal gating across eight gates with reasons, causal chain with timing, scenario impact, intervention chain, dimension findings.
-
Specialist.
Intervention readiness owner, regulator liaisonPlus irreversibility profile, failure profiles, single points of failure, framework pressure, regulatory mapping, JSON export, attestation envelope.
Intervention decision support.
A what-if console for the resilience function. Test whether proposed changes improve intervention timing without re-running the full assessment. Included with every tier.
How an engagement runs.
Five phases from named system to signed verdict. Each phase states what you provide, so the obligation is explicit before the work begins. At the short pilot format the five run inside four weeks.
- 01
Nominate.
You name one consequential system and the single intervention-readiness question it has to answer.
- 02
Scope.
Together you fix the success condition, the harm window, and the evidence the assessment will draw on.
- 03
Evidence.
You supply the control, escalation and drill evidence. It is graded for quality, not taken on assertion.
- 04
Assess.
A trained rater runs the SEDI assessment against the eight dimensions. No system access, no integration.
- 05
Deliver.
You receive the signed Intervention Readiness Verdict and Failure Exposure Report in three layers, executive, operational and specialist, with a board readout and a close-out memo recording agreed actions and ownership.
Three levels of assurance. Priced by decision significance.
The commercial unit is evidence of Intervention Readiness. Price comes after the question answered, the evidence produced, and the decision being supported.
Ahead of that, the Intervention Readiness Snapshot asks ten questions and names the area you are least able to evidence. No details required to see the result. The first engagement is the short pilot: one system, four weeks, one fixed price.
- Assurance level
Pilot.
Initial evidence for one consequential system.- Question answered
- Can this system be stopped before harm becomes irreversible?
- Who it is for
- Executive, risk or board teams facing a material deployment, approval, remediation or oversight decision.
- Evidence produced
- Formal AGDA™ SEDI verdict, Failure Exposure Report, signed regulator bundle, attestation envelope, board evidence readout and intervention scenario support.
- Decision supported
- Deployment confidence, risk acceptance, remediation priority, board oversight and regulatory preparation.
- Why it matters
- Creates a defensible evidence standard before the organisation relies on assertion or expands assessment across more systems.
Price- Short pilot · 1 system · four weeks £95,000 €110,000 · $125,000
- Structured pilot · 1 system £120,000 €140,000 · $155,000
- Structured pilot · 2 systems £175,000 €205,000 · $225,000
- Structured pilot · 3 systems £225,000 €265,000 · $290,000
Assessment scope. Failure Exposure Report at all three audience layers, signed regulator bundle, attestation envelope, Labs Intervention Simulator access, board evidence readout and close-out memo.
- Assurance level
Annual subscription.
Standing evidence for recurring assurance decisions.- Question answered
- Does Intervention Readiness remain evidenced as systems, dependence and operating conditions change?
- Who it is for
- Organisations that have completed a pilot and need recurring evidence for material systems.
- Evidence produced
- Two assessed systems per year, quarterly re-run rights, engine-hash pinning, updated verdicts and annual board evidence readout.
- Decision supported
- Continued deployment, control investment, oversight renewal, risk committee decisions and regulator-facing assurance.
- Why it matters
- Keeps the answer current as automation becomes more embedded and the cost of delayed intervention increases.
Price- Annual subscription £180,000 / yr €210,000 / yr · $235,000 / yr
- Equivalent quarterly £45,000 / qtr €52,500 / qtr · $58,750 / qtr
Assessment scope. Standing Labs access, two assessed systems per year, engine-hash pinning, quarterly re-run rights on each system, annual board evidence readout.
- Assurance level
Enterprise master.
Group-level evidence across systems and entities.- Question answered
- Can a complex organisation evidence intervention capability across the systems that matter most?
- Who it is for
- Multi-entity groups, regulated portfolios and organisations facing material automation exposure across several operating units.
- Evidence produced
- Portfolio-level Intervention Readiness verdicts, regulator-ready SEDI bundles where assessments are in scope, group CRO review, multi-entity reporting and designated AGDA™ operation.
- Decision supported
- Group assurance, regulatory engagement, critical deployment governance, resilience investment and board-level risk appetite.
- Why it matters
- Aligns evidence across entities so the board is not comparing local assertions against group-level exposure.
Price- Enterprise assurance · custom-scoped £350,000+ / yr €410,000+ / yr · $450,000+ / yr
Assessment scope. Up to 5 assessed systems per year, regulator-liaison support, quarterly portfolio review with group CRO, board evidence readouts, multi-entity invoicing, designated AGDA™ operator.
Custom scope applies when assurance spans multiple legal entities, material system portfolios or sustained regulator engagement.
Add-ons.
Additional evidence, re-runs and support when the decision requires more coverage. Priced per unit. No volume discount on the first deal in a sector.
- Additional assessed system, post-pilot £55,000 €65,000 · $72,000
- Additional re-run, beyond quarterly included in Annual £20,000 €23,000 · $25,000
- Additional named Labs operator £3,000 / term €3,500 / term · $4,000 / term
- Board evidence readout, remote £12,000 €14,000 · $15,500
- Board evidence readout, on-site £18,000 €21,000 · $23,000
- Regulator bundle, post-engine-version change £6,000 €7,000 · $7,500
Assessment support.
- Operator enablement, internal assurance team (up to 2 raters) £55,000 €64,000 · $70,000
- Operator enablement, external assurance firm £85,000 €99,000 · $108,000
- External assurance firm annual renewal £25,000 / yr €29,000 / yr · $32,000 / yr
- Regulator-liaison support block £18,000 €21,000 · $23,000
Prices shown in GBP, EUR, and USD. All exclude VAT. Sector premium of 30 to 50 percent applies to clinical AI, medical devices, critical infrastructure, and defence. Other currencies on application.
What AGDA™ is not.
The category boundary matters. AGDA™ measures Intervention Readiness. It does not sell governance theatre under another name.
-
Not a governance framework.
We do not score governance artefact completeness. We measure whether governance can actually intervene when required.
-
Not a compliance solution.
Regulatory exposure is an output of the assessment. The category is Intervention Readiness, not clause adherence.
-
Not a risk score.
AGDA™ produces a verdict on one question: can you stop it in time? It can inform a risk register. It does not substitute for one.
-
Not a monitoring tool.
AGDA™ assesses intervention capability at a point in time. Runtime monitoring is a different product category.
Where the assessment belongs.
AGDA™ is priced against board assurance, model risk and operational resilience budgets. Not software procurement.
-
Board assurance.
Where the question is whether oversight can actually intervene, not whether oversight has been described.
-
Model risk and operational resilience.
Where the system is material, automated, and capable of creating harm faster than authority can move.
-
Regulatory engagement preparation.
Where the organisation needs verifiable evidence of Intervention Readiness, not certification or regulatory approval.
AGDA™ at £95,000 for a pilot or £180,000 per year for an annual subscription turns that budget into a formal verdict on one question: can the organisation intervene before harm becomes irreversible? Formal SEDI assessments add a signed regulator bundle.
Nominate a system. Measure whether it can be stopped in time.
The pilot is sized around one consequential system and one Intervention Readiness question. Review the sample verdict first if you want to see the evidence standard.